0
APAC composite index score, of 100
APAC Bioeconomy Index
APAC Bioeconomy Index
Benchmarking the capability and commercial resilience of Asia-Pacific’s bioeconomy — twelve markets, six pillars, one independent read on where the region leads, where it lags, and what to do next.
For two decades, the definitive read on the bioeconomy has been written from the outside in — global benchmarks in which Asia-Pacific appears as a cluster of data points rather than the centre of the story. Yet by almost any measure that matters today, this region is where the future of the industry is being built.
The APAC Bioeconomy Index is our answer to that gap. It is the first benchmark designed from an Asia-Pacific vantage point — built around the pillars that actually determine competitiveness here, and honest about the region's three-speed reality rather than flattening it into a single global average.
Two convictions shaped it. First, that capability and commercial realisation are not the same thing — we found extraordinary scientific and industrial strength running well ahead of the ecosystems needed to convert it into market value. Second, that a benchmark of this kind must be independent: no single vendor, sponsor, or government sets its conclusions. This inaugural edition is a foundation, not a final word — and an annual commitment to track the region's progress, year over year.
Singapore leads at 78.4; more than 30 points separate the top of the table from the bottom. Filter by archetype, or sort any column — the spread is the story.
| Rank▲ | Market▲ | Score▲ | Archetype▲ | Index |
|---|
Across Asia-Pacific, the ability to do the science and build the capacity runs ahead of the ability to convert it into commercial value. That distance is the defining feature of the 2026 Index.
The region scores 65 on capability but just 57 on commercial realisation. The widest gaps sit with the Manufacturing Powerhouses — industrial strength that has outpaced the ecosystem around it. Use the Capability × Realisation toggle in the map above to see every market plotted.
Biomanufacturing and talent are the region’s twin strengths. Sustainability is the clear laggard. Tap any pillar to read the finding.
The Index is a compass, not a verdict — a way to focus investment, choose collaborators that close real gaps, and track progress year over year.
The complete inaugural edition, in one PDF — everything the map and highlights above are drawn from.
